TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2025

Income Metrics

Revenue 1.2B
Gross Profit 198.8M 16.19%
Operating Income 103.9M 8.46%
Net Income 84.5M 6.88%
EPS (Diluted) $1.44

Balance Sheet Metrics

Total Assets 4.8B
Total Liabilities 2.8B
Shareholders Equity 1.9B
Debt to Equity 1.47

Cash Flow Metrics

Operating Cash Flow 97.9M
Free Cash Flow 29.3M

Revenue & Profitability Trend

Ensign Group Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i4.3B3.7B3.0B2.6B2.4B
Cost of Goods Sold i3.6B3.1B2.5B2.2B2.0B
Gross Profit i667.6M590.8M518.0M468.2M407.5M
Gross Margin % i15.7%15.8%17.1%17.8%17.0%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i225.1M263.0M158.8M151.8M129.7M
Other Operating Expenses i-----
Total Operating Expenses i225.1M263.0M158.8M151.8M129.7M
Operating Income i358.3M255.4M296.8M260.5M223.2M
Operating Margin % i8.4%6.8%9.8%9.9%9.3%
Non-Operating Items
Interest Income i28.7M--4.4M3.8M
Interest Expense i8.3M8.1M8.9M6.8M9.4M
Other Non-Operating Income7.3M25.5M1.2M4.4M-
Pre-tax Income i386.1M272.8M289.1M258.0M217.6M
Income Tax i87.6M62.9M64.4M60.3M46.2M
Effective Tax Rate % i22.7%23.1%22.3%23.4%21.3%
Net Income i298.5M209.8M224.7M197.7M171.4M
Net Margin % i7.0%5.6%7.4%7.5%7.1%
Key Metrics
EBITDA i478.5M353.2M360.4M320.8M281.5M
EPS (Basic) i$5.26$3.76$4.09$3.57$3.19
EPS (Diluted) i$5.12$3.65$3.95$3.42$3.06
Basic Shares Outstanding i5665500055708000548870005448600053434000
Diluted Shares Outstanding i5665500055708000548870005448600053434000

Income Statement Trend

Ensign Group Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i464.6M509.6M316.3M262.2M236.6M
Short-term Investments i62.3M17.2M15.4M13.8M13.4M
Accounts Receivable i569.9M485.0M408.4M328.7M305.1M
Inventory i-----
Other Current Assets60.9M35.0M41.0M29.6M-
Total Current Assets i1.2B1.0B781.1M639.7M583.0M
Non-Current Assets
Property, Plant & Equipment i2.3B2.1B1.7B1.4B1.3B
Goodwill i203.3M160.3M160.2M127.3M115.6M
Intangible Assets i7.3M6.5M6.4M6.4M6.6M
Long-term Investments-----
Other Non-Current Assets112.8M104.7M74.4M60.1M53.3M
Total Non-Current Assets i3.5B3.1B2.7B2.2B2.0B
Total Assets i4.7B4.2B3.5B2.9B2.5B
Liabilities
Current Liabilities
Accounts Payable i98.9M92.8M77.1M58.1M50.9M
Short-term Debt i97.6M86.5M69.7M55.9M51.1M
Current Portion of Long-term Debt-----
Other Current Liabilities----102.0M
Total Current Liabilities i743.4M734.7M582.1M523.1M562.4M
Non-Current Liabilities
Long-term Debt i1.9B1.8B1.5B1.2B1.1B
Deferred Tax Liabilities i-----
Other Non-Current Liabilities64.2M49.4M33.3M27.1M39.7M
Total Non-Current Liabilities i2.1B1.9B1.6B1.3B1.2B
Total Liabilities i2.8B2.7B2.2B1.8B1.7B
Equity
Common Stock i61.0K60.0K59.0K58.0K58.0K
Retained Earnings i1.4B1.1B946.3M734.0M551.1M
Treasury Stock i117.8M116.6M114.6M83.0M71.2M
Other Equity-----
Total Shareholders Equity i1.8B1.5B1.2B1.0B818.2M
Key Metrics
Total Debt i2.0B1.9B1.6B1.3B1.1B
Working Capital i414.2M312.2M199.1M116.6M20.6M

Balance Sheet Composition

Ensign Group Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i298.5M209.8M224.7M197.7M171.4M
Depreciation & Amortization i84.1M72.4M62.4M56.0M54.6M
Stock-Based Compensation i36.2M30.8M22.7M18.7M14.5M
Working Capital Changes i-80.2M-70.5M-88.4M-53.6M7.9M
Operating Cash Flow i338.1M265.0M222.1M220.8M270.8M
Investing Activities
Capital Expenditures i-158.2M-106.2M-87.5M-69.6M-49.9M
Acquisitions i-156.5M0-16.4M-8.0M0
Investment Purchases i-105.1M-29.6M-22.0M-32.3M-21.7M
Investment Sales i26.4M18.9M14.4M27.5M24.5M
Investing Cash Flow i-390.1M-182.7M-186.2M-173.8M-58.7M
Financing Activities
Share Repurchases i-1.2M-1.9M-31.6M-11.8M-25.9M
Dividends Paid i-13.7M-12.9M-12.2M-11.5M-10.8M
Debt Issuance i400.0K150.0K411.0K45.2M417.2M
Debt Repayment i-4.4M-4.0M-4.1M-3.1M-629.7M
Financing Cash Flow i-24.4M-19.0M-44.9M-43.2M-362.5M
Free Cash Flow i188.9M270.5M185.0M206.0M323.0M
Net Change in Cash i-76.4M63.3M-9.0M3.9M-150.4M

Cash Flow Trend

Ensign Group Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 30.66
Forward P/E 27.56
Price to Book 4.80
Price to Sales 2.12
PEG Ratio 1.76

Profitability Ratios

Profit Margin 7.00%
Operating Margin 8.46%
Return on Equity 17.54%
Return on Assets 5.30%

Financial Health

Current Ratio 1.41
Debt to Equity 100.93
Beta 1.02

Per Share Data

EPS (TTM) $5.52
Book Value per Share $35.23
Revenue per Share $80.96

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
ensg9.8B30.664.8017.54%7.00%100.93
HCA Healthcare 94.6B16.99-77.2513,631.68%8.21%-37.45
Tenet Healthcare 15.7B11.154.1829.65%7.18%158.70
DaVita 9.8B13.556.8657.94%6.35%825.19
Chemed 6.6B23.365.5024.14%11.56%12.15
Option Care Health 4.7B22.813.4315.25%3.93%90.35

Financial data is updated regularly. All figures are in the company's reporting currency.